Skip to main content
SpringerLink
Log in

Pharmacist intervention to reduce CV risk reduces healthcare costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2017 Canadian dollars

Reference

  • Tam-Tham H, et al. A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH). Value in Health : 17 Aug 2019. Available from: URL: https://doi.org/10.1016/j.jval.2019.05.012

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pharmacist intervention to reduce CV risk reduces healthcare costs. PharmacoEcon Outcomes News 836, 22 (2019). https://doi.org/10.1007/s40274-019-6195-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6195-9

Search

Navigation